apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

GLIO-CMV-01: Identification of immune biomarkers for CMV-related encephalitis during radiotherapy of the brain (2018) Donaubauer AJ, Becker I, Rühle PF, Goerig N, Pohn A, Winkler T, Korn K, et al. Conference contribution Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies (2018) Rueckert M, Fietkau R, Frey B, Hecht M, Gaipl U, Deloch L Journal article, Review article IONISING RADIATION INHIBITS INFLAMMATION IN PATIENTS WITH MUSCULOSKELETAL DISEASES: RADON TREATMENT VS LOW-DOSE RADIATION THERAPY (2018) Shreder K, Cucu A, Kraft D, Lehrian S, Kondol J, Klein G, Frey B, et al. Conference contribution Ex vivo heat treatment of B16 melanoma and MCF-7 breast cancer cells by warm-water or microwave radiation in a closed-loop reactor (2018) Hader M, Rosin A, Blank T, Wadepohl M, Gaipl U, Frey B Conference contribution Anti-tumor immune responses in primary and abscopal tumors differently depend on radiotherapy fractionation and immunotherapy modalities (2018) Rueckert M, Frey B, Fietkau R, Gaipl U Conference contribution Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System (2018) Falcke S, Rühle PF, Fietkau R, Frey B, Gaipl U, Deloch L Journal article, Original article Comparative study and simulation of tumor cell inactivation by microwave and conventional heating (2018) Rosin A, Hader M, Drescher C, Suntinger M, Gerdes T, Willert-Porada M, Gaipl U, Frey B Journal article Systemic effects of radiotherapy: immune mechanisms, pre-clinical data and clinical evidence (2018) Gaipl U Conference contribution Radiation and checkpoint Blockade in the treatment of metastases (2018) Hirschmann E, Gaipl U, Fietkau R, Distel L, Hecht M Conference contribution Predictive character of peripheral blood immunophenotype before and during treatment with PD-1 immune checkpoint inhibitors (interim analysis of the prospective phase IV ST-ICI trial) (2018) Hecht M, Harrer A, Rutzner S, Lettmaier S, Wolf W, Fietkau R, Frey B, Gaipl U Conference contribution